Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Healthcare Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product
6.1 Therapeutics
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Vaccines
6.1.2.2 Parasiticides
6.1.2.3 Anti-Infectives
6.1.2.4 Medical Feed Additives
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Diagnostics
6.2.1 Market Trends
6.2.2 Key segments
6.2.2.1 Immunodiagnostic Tests
6.2.2.2 Molecular Diagnostics
6.2.2.3 Diagnostic Imaging
6.2.2.4 Clinical Chemistry
6.2.2.5 Others
6.2.3 Market Forecast

7 Market Breakup by Animal Type
7.1 Dogs and Cats
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Horses
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ruminants
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Swine
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Poultry
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast

8 Market Breakup by End User
8.1 Veterinary Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Veterinary Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Veterinary Laboratory Testing Services
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Animalcare Group plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Ceva Animal Health LLC
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Dechra Pharmaceuticals PLC
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Elanco Animal Health Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Heska Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 IDEXX Laboratories Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 INDICAL Bioscience GmbH (Vimian Group)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Merck & Co. Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Norbrook Laboratories Ltd
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Vetoquinol India Animal Health Pvt Ltd (V?toquinol S.A.)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Virbac
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Zoetis Inc. (Pfizer Inc.)
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis